This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03462/identifier/chebi/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03462/identifier/kegg-compound/
n16http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB03462/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03462/identifier/bindingdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03462/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB03462/identifier/pubchem-substance/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03462/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03462
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n15:DB03462 n16:DB03462
dcterms:title
Thymine
adms:identifier
n7:46507372 n8:TDR n9:50134397 n10:1135 n11:17821 n12:DB03462 n13:C00178
n3:synthesisReference
Charles W. Murtiashaw, "Process for the production of O.sup. 2,2'-anhydro-1-(.beta.-D-arabinofuranosyl)thymine." U.S. Patent US5008384, issued February, 1988.
n3:IUPAC-Name
n4:271B4A71-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4A77-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4A76-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4A73-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4A74-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4A75-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4A87-363D-11E5-9242-09173F13E4C5 n4:271B4A6F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4A6D-363D-11E5-9242-09173F13E4C5 n4:271B4A89-363D-11E5-9242-09173F13E4C5 n4:271B4A70-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4A8A-363D-11E5-9242-09173F13E4C5 n4:271B4A6E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4A7D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4A7E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4A78-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4A79-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4A7B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4A7A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4A7C-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
65-71-4
n3:Bioavailability
n4:271B4A83-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4A85-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4A86-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4A88-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4A82-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4A81-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4A84-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4A72-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4A7F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4A80-363D-11E5-9242-09173F13E4C5